Ultime notizie per ConneXionONE (OTC:CNNN) Azioni

ConneXionONE Corp is a technology company revolutionizing social media with its flagship product, dotarazzi. The Company is a development-stage company that plans to be involved in social media and internet advertising and marketing services with a decentralized social media platform.

ConneXionONE Corp

Highlighting Tumor-Targeted T Cell Activation and CD40 Modulation in Solid Tumors at SITC 2024

Biotech

News

General

MOLN

Molecular Partners Unveils Preclinical Proof-Of-Concept For CD3 Switch-DARPin T Cell Engager And Clinical Biomarker Insights For MP0317

Guidance

Sprout Social Sees Q4 Revenue $106.3M-$107.1M; Q4 Adj. EPS $0.15-$0.16.

Ameresco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMRC#NYSE">AMRC</a>) affirms FY2024 Adj EPS guidance from $1.15-1.35 to $1.15-1.35 vs $1.14 analyst estimate. Affirms FY2024 sales outlook from $1.70 billion-1.80 billion to $1.70 billion-1.80 billion vs $1.74 billion estimate.

AMRC

Ameresco Affirms FY2024 Adj EPS Guidance from $1.15-1.35 to $1.15-1.35 vs $1.14 Est; Affirms FY2024 Sales Guidance from $1.70B-1.80B to $1.70B-1.80B vs $1.74B Est

Inogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INGN#NASDAQ">INGN</a>) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.49) by 77.55 percent. This is a 69.44 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $88.83 million which beat the analyst consensus estimate of $84.14 million by 5.58 percent. This is a 5.80 percent increase over sales of $83.97 million the same period last year.

Earnings

Earnings Beats

INGN

Inogen Q3 Adj $(0.11) Beats $(0.49) Estimate, Sales $88.83M Beat $84.14M Estimate

CarGurus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARG#NASDAQ">CARG</a>) is looking for Q4 Adj EPS of $0.50-0.55 vs $0.46 analyst estimate. sees sales of $219.000 million-239.000 million vs $225.58 million estimate.

CARG

CarGurus Sees Q4 Adj EPS $0.50-0.55 vs $0.46 Est; Sees Sales $219.000M-239.000M vs $225.58M Est

W&T Offshore Sees FY24 Total Equivalents (MBoe) 11,900 – 13,267

W&T Offshore Sees Q4 Total Equivalents (MBoe) 2,927-3,253

IONQ

IonQ Partners With imec To Enhance Quantum Computing Scale And Performance Using Photonic Integrated Circuits, Aiming To Increase Qubit Count, Improve System Efficiency, And Reduce Costs For Next-Gen Quantum Computers

Sprout Social Sees FY24 Revenue $405.1M-$405.9M Vs $405.535M Est; FY24 Adj. EPS $0.46-$0.47 Vs $0.46 Est.

FY2025 Guidance
&nbsp;
<ul>
<li>The Company is providing preliminary FY2025 guidance of $12.00 Adjusted Net Income per Diluted Share with the expectation of being a full corporate taxpayer throughout the year (20%-25% effective tax rate).</li>
</ul>

SEZL

Sezzle Is Providing Preliminary FY25 Guidance Of $12.00 Adjusted Net Income Per Diluted Share With The Expectation Of Being A Full Corporate Taxpayer Throughout The Year (20%-25% Effective Tax Rate) Vs $10.09 Est.

SEMR

SEMrush Sees Q4 Total Revenue $100.8M-$101.8M vs $101.03M Est., Sees FY24 Total Revenue $375M-$376M vs $374.45M Est.

Block, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>) reported its third-quarter results after Thursday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/11/b41823717/block-announces-third-quarter-2024-results">details from the report.&nbsp;</a>
The Details:&nbsp;Block reported quarterly earnings of 88 cents per share, which beat the analyst consensus estimate of 87 cents. Quarterly revenue came in at $5.97 billion which missed the analyst consensus estimate of $6.24 billion and is an increase over sales of $5.617 billion from the same period last year.
<ul>
<li>Square generated a gross profit of $932 million, up 16% year-over-year.</li>
<li>Cash App generated a gross profit of $1.31 billion, up 21% year-over-year.</li>
</ul>
Read Next: <a href="https://www.benzinga.com/news/24/11/41781921/what-does-trumps-victory-mean-for-ev-giant-tesla-and-the-big-3-automakers">What Does Trump&#8217;s Victory Mean For EV Giant Tesla And The Big 3 Automakers?</a>
&#8220;We outperformed our gross profit and profitability guidance in the third quarter of 2024. Gross profit grew 19% year over year to $2.25 billion. Cash App continued its strong performance with gross profit growth of 21% year over year, driven primarily by growth in inflows per active and an increase in monetization rate,&#8221; Block wrote in a letter to shareholders.
&#8220;There was strong performance across Cash App Card, Cash App Borrow and our BNPL platform. Square gross profit grew 16% year over year in the third quarter, in line with our expectations, behind strength in our software and integrated payments and banking products,&#8221; the company added.
SQ Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Block shares are down 7.69% after-hours at $69.25 at the time of publication Thursday.
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41822473/trumps-potential-health-czar-robert-f-kennedy-jr-rattles-vaccine-stocks-shoot-first-reaction">Trump&#8217;s Potential &#8216;Health Czar&#8217; Robert F. Kennedy Jr. Rattles Vaccine Stocks: &#8216;Shoot First Reaction&#8217;</a></li>
</ul>
Photo: Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

After-Hours Center

Movers

Block Shares Sink After Mixed Q3 Results: EPS Beat, Revenues Miss

nLight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASR#NASDAQ">LASR</a>) sees Q4 sales of $49.000 million-54.000 million vs $59.88 million estimate.

LASR

nLight Sees Q4 Sales $49.000M-54.000M vs $59.88M Est

Maravai LifeSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVI#NASDAQ">MRVI</a>) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.01) by 100 percent. The company reported quarterly sales of $65.200 million which missed the analyst consensus estimate of $67.555 million by 3.49 percent. This is a 2.49 percent decrease over sales of $66.865 million the same period last year.

Earnings Misses

MRVI

Maravai LifeSciences Q3 2024 Adj. EPS $(0.02) Misses $(0.01) Estimate, Sales $65.200M Miss $67.555M Estimate

Joint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYNT#NASDAQ">JYNT</a>) System-wide sales are expected to be between $525 million and $535 million.

JYNT

Joint Corp. FY 2024 System-wide sales are expected to be between $525 million and $535 million.

Updated FY2024 Guidance
&nbsp;
<ul>
<li>The Company is raising several components of its FY2024 guidance due to: 1) continued sustained growth, and 2) the inclusion of the newly launched banking program with WebBank, which was not accounted for in previous guidance.</li>
<li>&nbsp;
<ul>
<li>Net Income: $71.5 million versus $55.0 million provided with 2Q24 earnings.</li>
</ul>
</li>
<li>&nbsp;
<ul>
<li>Net Income per Diluted Share: $12.05 versus $9.25 provided with 2Q24 earnings.</li>
</ul>
</li>
<li>&nbsp;
<ul>
<li>Total Revenue Growth: 55% versus 35%-40% provided with 2Q24 earnings.</li>
</ul>
</li>
<li>&nbsp;
<ul>
<li>Total Revenue Less Transaction Related Costs as a percentage of Total Revenue: No change to the 55% provided with 2Q24 earnings.</li>
</ul>
</li>
<li>Additionally, updating the FY2024 guidance for the following metrics that adjust for certain significant gains, losses, and charges that may not directly correlate to the underlying performance of the Company's business:</li>
<li>&nbsp;
<ul>
<li>Adjusted Net Income<a href="http:/#_ftn2">[2]</a>: $58.0 million versus $40.0 million provided with 2Q24 earnings.</li>
</ul>
</li>
<li>&nbsp;
<ul>
<li>Adjusted Net Income per Diluted Share2: $9.80 versus $6.75 provided with 2Q24 earnings.</li>
</ul>
</li>
<li>The Company expects a mid-single digit annualized effective tax before consideration of discrete tax items for 4Q24.</li>
</ul>

Sezzle Increases FY24 Revenue Growth Guidance From 35%-40% To 55%; Adj. Net Income Per Diluted Share From $6.75 To $9.80 Vs $6.73 Est.; Adj. Net Income From $40M To $58M

FIGS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIGS#NYSE">FIGS</a>) lowers FY2024 sales outlook from $545.65 million-556.56 million to $540.19 million-545.65 million.

FIGS

FIGS Lowers FY2024 Sales Guidance from $545.65M-556.56M to $540.19M-545.65M

ALX Oncology Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALXO#NASDAQ">ALXO</a>) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.79) by 26.58 percent.

ALXO

ALX Oncology Holdings Q3 2024 GAAP EPS $(0.58) Beats $(0.79) Estimate

CryoPort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYRX#NASDAQ">CYRX</a>) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.31) by 93.55 percent. The company reported quarterly sales of $56.664 million which missed the analyst consensus estimate of $58.042 million by 2.37 percent. This is a 0.90 percent increase over sales of $56.157 million the same period last year.

CYRX

CryoPort Q3 2024 GAAP EPS $(0.02) Beats $(0.31) Estimate, Sales $56.664M Miss $58.042M Estimate

Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by 30 percent. This is a 41.67 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $190.00 thousand which missed the analyst consensus estimate of $2.25 million by 91.56 percent. This is a 81.85 percent decrease over sales of $1.05 million the same period last year.

MVIS

Microvision Q3 EPS $(0.07) Beats $(0.10) Estimate, Sales $190.00K Miss $2.25M Estimate

An announcement from Connexionone ( ($CNNN) ) is now available. Christine Chang stepped down as CEO of the Company for personal reasons, effective ...

Connexionone Announces CEO Transition and Board Continuity

CNNN

Press Releases

ConneXionONE Corp. (OTC: CNNN) Announces Approval of Dotarazzi App on iOS (Apple) and Android Launch, Setting the Stage for Global Expansion

ConneXionONE Corp (OTC: CNNN) Announces Successful Dotarazzi Launch Event in Taiwan, Paving the Way for A Game-Changing Social Media Platform Set to Revolutionize Global User Engagement

Comments

ConneXionONE

Notizie

Ultime notizie per ConneXionONE (OTC:CNNN) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO